[Consciousness disorders in the aged due to therapeutic drugs].
Watanabe
R
R
D000368:Aged; D000740:Anemia / Q000139:chemically induced; D003072:Cognition Disorders / Q000139:chemically induced*; D003244:Consciousness Disorders / Q000139:chemically induced*; D004347:Drug Interactions; D005444:Flunarizine / Q000009:adverse effects; D006801:Humans; D007408:Intestinal Absorption; D010205:Pantothenic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D010276:Parasympatholytics / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000209:etiology; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000493:pharmacokinetics; D012202:Reye Syndrome / Q000139:chemically induced; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D010276:Parasympatholytics; D011619:Psychotropic Drugs; C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid; D005444:Flunarizine